levodopa has been researched along with methylcellulose in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlskog, JE; Bailey, PA; Muenter, MD; Stevens, PM | 1 |
| Baumann, G; Chin, L; Lieberman, A | 1 |
| Allahham, A; Mainwaring, D; Marriott, J; Stewart, P | 1 |
| Amighi, K; Goole, J; Vanderbist, F | 1 |
| Dorozyński, P; Jachowicz, R; Kulinowski, P; Weglarz, WP | 1 |
| Dorożyński, P; Jachowicz, R; Kulinowski, P; Mendyk, A | 1 |
6 other study(ies) available for levodopa and methylcellulose
| Article | Year |
|---|---|
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Lactose; Levodopa; Male; Methylcellulose; Middle Aged; Oxazines; Parkinson Disease; Pergolide | 1992 |
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease.
Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine | 1988 |
Factors affecting shear thickening behavior of a concentrated injectable suspension of levodopa.
Topics: Chemistry, Pharmaceutical; Dopamine Agents; Hypromellose Derivatives; Injections, Subcutaneous; Levodopa; Methylcellulose; Particle Size; Pharmaceutical Vehicles; Rheology; Stress, Mechanical; Suspensions; Viscosity | 2005 |
Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms.
Topics: Adhesiveness; Antiparkinson Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Compounding; Excipients; Hydrogen-Ion Concentration; Levodopa; Methylcellulose; Solubility; Tablets | 2007 |
An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
Topics: Capsules; Chemistry, Pharmaceutical; Computer Simulation; Delayed-Action Preparations; Diffusion; Dosage Forms; Drug Combinations; Equipment Design; Fasting; Gastric Mucosa; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogen-Ion Concentration; Hypromellose Derivatives; Levodopa; Magnetic Resonance Imaging; Methylcellulose; Physiological Phenomena; Polymers; Solubility; Solvents; Tablets; Technology, Pharmaceutical; Temperature; Time Factors; Water | 2008 |
Gastroretentive drug delivery systems with L-dopa based on carrageenans and hydroxypropylmethylcellulose.
Topics: Administration, Oral; Carrageenan; Chemistry, Pharmaceutical; Dosage Forms; Drug Carriers; Drug Compounding; Hypromellose Derivatives; Kinetics; Levodopa; Linear Models; Magnetic Resonance Imaging; Methylcellulose; Models, Chemical; Solubility; Stomach; Technology, Pharmaceutical | 2011 |